质子抑制剂使用与慢性病进展通过过程采矿方法的关联的评估
Kaile Chen1,2, Farhad Abtahi1,2,3, Hong Xu4
1Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 17177 Stockholm, Sweden.
质子抑制剂 (PPI) 的使用与慢性病 (CKD) 的更快进展有关. 这项研究发现,与H2阻断剂使用者相比,PPI使用者的CKD进展到严重CKD阶段的风险高出75%.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 数据科学数据科学数据科学
背景情况:
- 以前的研究表明,质子抑制剂 (PPI) 与慢性病 (CKD) 进展之间存在联系.
- 了解PPI对功能下降的影响对于患者管理至关重要.
研究的目的:
- 评估PPI使用与CKD进展之间的关联.
- 使用过程挖掘分析估计的膜过率 (eGFR) 轨迹.
主要方法:
- 使用斯德哥尔摩肌素测量 (SCREAM) 数据进行的回顾性队列研究 (2006-2011).
- 鉴定出新的PPI和H2阻断剂 (H2Bs) 用户患有CKD (eGFR<60).
- 使用过程挖掘来建模纵向的eGFR轨迹.
主要成果:
- 与H2B用户相比,PPI用户显示出更复杂和快速下降的eGFR轨迹.
- 使用PPI与从中度到严重的CKD阶段过渡的风险增加了75% (aHR1.75).
结论:
- 使用PPI与CKD进展的风险增加有关.
- 在流行病学中,过程挖掘是分析疾病纵向进展的宝贵工具.
更多相关视频
10:37Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
相关概念视频
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
The pKa of a...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drug Elimination by Renal Route: Tubular Secretion
Renal Drug Excretion: Tubular Secretion
Drug Elimination by Renal Route: Tubular Reabsorption
